Actively Recruiting
Dexmedetomidine, Magnesium Sulphate and Lidocaine for Cough Suppression After General Anesthesia
Led by Al-Azhar University · Updated on 2025-06-11
300
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this prospective randomized controlled double-blinded study is to compare the efficacy of dexmedetomidine, MgSO4 and lidocaine for cough suppression during general anesthetic emergence as regard number and severity.
CONDITIONS
Official Title
Dexmedetomidine, Magnesium Sulphate and Lidocaine for Cough Suppression After General Anesthesia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 21-60 years
- Both genders
- Body mass index < 30 kg/m2
- American Society of Anesthesiology (ASA) physical status I-II
- Mallampati score class I or II
- Patients undergoing surgery under general anesthesia
You will not qualify if you...
- Known allergy to study drugs
- History of psychiatric illness
- Patients with major organ diseases
- Pre-existing neurological deficits
- Body mass index > 30 kg/m2
- Active airway infection or history of tracheal and laryngeal surgery
- Lower esophageal sphincter incompetence and reflux
- Increased intracranial and intraocular pressure
- Use of cough-inducing medications
- Pregnant and lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Medicine, Al-Azhar university Assiut, Egypt.
Asyut, Egypt, 2091110
Actively Recruiting
Research Team
M
Medhat H Allam, lecturer.MD
CONTACT
O
Osama H Ahmed, Professor.MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here